Improving expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 90卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [11] Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
    Porter, David L.
    Levine, Bruce L.
    Kalos, Michael
    Bagg, Adam
    June, Carl H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08): : 725 - 733
  • [12] Kinetics of Tumor Destruction by Chimeric Antigen Receptor-modified T Cells
    Anurathapan, Usanarat
    Chan, Robert C.
    Hindi, Hakeem F.
    Mucharla, Roopa
    Bajgain, Pradip
    Hayes, Brendan C.
    Fisher, William E.
    Heslop, Helen E.
    Rooney, Cliona M.
    Brenner, Malcolm K.
    Leen, Ann M.
    Vera, Juan F.
    MOLECULAR THERAPY, 2014, 22 (03) : 623 - 633
  • [13] Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
    O'Hara, Mark
    Stashwick, Caitlin
    Haas, Andrew R.
    Tanyi, Janos L.
    IMMUNOTHERAPY, 2016, 8 (04) : 449 - 460
  • [14] Development of chimeric antigen receptor-modified T cells for the treatment of esophageal cancer
    Yu, Feng
    Wang, Xiaoyan
    Shi, Hui
    Jiang, Maorong
    Xu, Jun
    Sun, Min
    Xu, Qinggang
    Addai, Frank Peprah
    Shi, Haifeng
    Gu, Jie
    Zhou, Yang
    Liu, Liqiong
    TUMORI JOURNAL, 2021, 107 (04): : 341 - 352
  • [15] Killing cervical cancer cells by specific chimeric antigen receptor-modified T cells
    He, Yue
    Li, Xing-Ming
    Yin, Cheng-Hong
    Wu, Yu-Mei
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2020, 139
  • [16] Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
    Jensen, Michael C.
    Riddell, Stanley R.
    IMMUNOLOGICAL REVIEWS, 2014, 257 (01) : 127 - 144
  • [17] Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects
    Guo, Yelei
    Wang, Yao
    Han, Weidong
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [18] Chimeric Antigen Receptor-Modified T Cell Immunotherapy for Relapsed and Refractory Adult Burkitt Lymphoma
    Wu, Jiaying
    Cao, Yang
    Zhang, Qi
    Liu, Wanying
    Zhou, Xiaoxi
    Ming, Xi
    Meng, Fankai
    Zhang, Yicheng
    Li, Chunrui
    Huang, Liang
    Wei, Jia
    Zheng, Miao
    Zhang, Shangkun
    Zhang, Tongcun
    Zhu, Xiaojian
    Wang, Na
    Wang, Jue
    Wang, Gaoxiang
    Zhou, Jianfeng
    Liu, Bo
    Xiao, Yi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [19] Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy
    Huang, Y.
    Li, D.
    Qin, D-Y
    Gou, H-F
    Wei, W.
    Wang, Y-S
    Wei, Y-Q
    Wang, W.
    GENE THERAPY, 2018, 25 (03) : 192 - 197
  • [20] Chimeric antigen receptor-modified T cells: CD19 and the road beyond
    Salter, Alexander I.
    Pont, Margot J.
    Riddell, Stanley R.
    BLOOD, 2018, 131 (24) : 2621 - 2629
12345